annual cash & cash equivalents:
$600.89M-$4.49M(-0.74%)Summary
- As of today (May 29, 2025), EXAS annual cash & cash equivalents is $600.89 million, with the most recent change of -$4.49 million (-0.74%) on December 31, 2024.
- During the last 3 years, EXAS annual cash & cash equivalents has risen by +$285.42 million (+90.47%).
- EXAS annual cash & cash equivalents is now -59.71% below its all-time high of $1.49 billion, reached on December 31, 2020.
Performance
EXAS Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$347.13M-$253.76M(-42.23%)Summary
- As of today (May 29, 2025), EXAS quarterly cash & cash equivalents is $347.13 million, with the most recent change of -$253.76 million (-42.23%) on March 31, 2025.
- Over the past year, EXAS quarterly cash & cash equivalents has dropped by -$360.00 thousand (-0.10%).
- EXAS quarterly cash & cash equivalents is now -76.72% below its all-time high of $1.49 billion, reached on December 31, 2020.
Performance
EXAS quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EXAS Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.7% | -0.1% |
| 3 y3 years | +90.5% | +82.9% |
| 5 y5 years | +239.0% | -50.5% |
EXAS Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.7% | +147.8% | -42.7% | +82.9% |
| 5 y | 5-year | -59.7% | +239.0% | -76.7% | +82.9% |
| alltime | all time | -59.7% | >+9999.0% | -76.7% | +9555.8% |
EXAS Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $347.13M(-42.2%) |
| Dec 2024 | $600.89M(-0.7%) | $600.89M(+2.0%) |
| Sep 2024 | - | $588.83M(+11.1%) |
| Jun 2024 | - | $530.18M(+52.6%) |
| Mar 2024 | - | $347.49M(-42.6%) |
| Dec 2023 | $605.38M(+149.6%) | $605.38M(+1.8%) |
| Sep 2023 | - | $594.61M(-1.6%) |
| Jun 2023 | - | $604.36M(+43.4%) |
| Mar 2023 | - | $421.37M(+73.8%) |
| Dec 2022 | $242.49M(-23.1%) | $242.49M(+3.1%) |
| Sep 2022 | - | $235.31M(+10.3%) |
| Jun 2022 | - | $213.42M(+12.5%) |
| Mar 2022 | - | $189.78M(-39.8%) |
| Dec 2021 | $315.47M(-78.8%) | $315.47M(+15.2%) |
| Sep 2021 | - | $273.78M(-24.7%) |
| Jun 2021 | - | $363.71M(-67.0%) |
| Mar 2021 | - | $1.10B(-26.0%) |
| Dec 2020 | $1.49B(+741.3%) | $1.49B(+84.9%) |
| Sep 2020 | - | $806.68M(+14.6%) |
| Jun 2020 | - | $703.93M(+0.4%) |
| Mar 2020 | - | $701.05M(+295.5%) |
| Dec 2019 | $177.25M(+10.5%) | $177.25M(-82.9%) |
| Sep 2019 | - | $1.03B(+404.4%) |
| Jun 2019 | - | $205.06M(-28.1%) |
| Mar 2019 | - | $285.20M(+77.8%) |
| Dec 2018 | $160.43M(+107.0%) | $160.43M(-0.8%) |
| Sep 2018 | - | $161.71M(-28.3%) |
| Jun 2018 | - | $225.66M(+51.8%) |
| Mar 2018 | - | $148.69M(+91.9%) |
| Dec 2017 | $77.49M(+58.4%) | $77.49M(+52.4%) |
| Sep 2017 | - | $50.84M(-71.8%) |
| Jun 2017 | - | $180.41M(+360.2%) |
| Mar 2017 | - | $39.21M(-19.9%) |
| Dec 2016 | $48.92M(+18.9%) | $48.92M(-22.9%) |
| Sep 2016 | - | $63.45M(+29.5%) |
| Jun 2016 | - | $49.01M(-6.0%) |
| Mar 2016 | - | $52.15M(+26.8%) |
| Dec 2015 | $41.13M(-29.2%) | $41.13M(+30.5%) |
| Sep 2015 | - | $31.52M(-6.6%) |
| Jun 2015 | - | $33.77M(-17.0%) |
| Mar 2015 | - | $40.68M(-30.0%) |
| Dec 2014 | $58.13M(+352.3%) | $58.13M(+108.9%) |
| Sep 2014 | - | $27.83M(+34.4%) |
| Jun 2014 | - | $20.71M(+16.3%) |
| Mar 2014 | - | $17.81M(+38.6%) |
| Dec 2013 | $12.85M(-3.7%) | $12.85M(+32.3%) |
| Sep 2013 | - | $9.71M(-54.9%) |
| Jun 2013 | - | $21.52M(+167.2%) |
| Mar 2013 | - | $8.05M(-39.7%) |
| Dec 2012 | $13.35M | $13.35M(+5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $12.66M(+110.1%) |
| Jun 2012 | - | $6.03M(-51.0%) |
| Mar 2012 | - | $12.29M(-65.6%) |
| Dec 2011 | $35.78M(-54.6%) | $35.78M(+616.3%) |
| Sep 2011 | - | $5.00M(-86.9%) |
| Jun 2011 | - | $38.26M(-46.9%) |
| Mar 2011 | - | $72.07M(-8.5%) |
| Dec 2010 | $78.75M(+259.2%) | $78.75M(+278.3%) |
| Sep 2010 | - | $20.82M(-14.1%) |
| Jun 2010 | - | $24.23M(+33.4%) |
| Mar 2010 | - | $18.17M(-17.1%) |
| Dec 2009 | $21.92M(+344.1%) | $21.92M(-3.8%) |
| Sep 2009 | - | $22.78M(+85.4%) |
| Jun 2009 | - | $12.29M(+241.8%) |
| Mar 2009 | - | $3.60M(-27.2%) |
| Dec 2008 | $4.94M(+10.1%) | $4.94M(-18.7%) |
| Sep 2008 | - | $6.07M(+10.3%) |
| Jun 2008 | - | $5.50M(+37.6%) |
| Mar 2008 | - | $4.00M(-10.9%) |
| Dec 2007 | $4.49M(-7.1%) | $4.49M(-37.4%) |
| Sep 2007 | - | $7.16M(+86.8%) |
| Jun 2007 | - | $3.83M(-0.4%) |
| Mar 2007 | - | $3.85M(-20.3%) |
| Dec 2006 | $4.83M(-62.9%) | $4.83M(-39.5%) |
| Sep 2006 | - | $7.99M(-42.2%) |
| Jun 2006 | - | $13.83M(+33.1%) |
| Mar 2006 | - | $10.39M(-20.1%) |
| Dec 2005 | $13.01M(-0.6%) | $13.01M(-24.0%) |
| Sep 2005 | - | $17.12M(-2.8%) |
| Jun 2005 | - | $17.63M(+88.8%) |
| Mar 2005 | - | $9.33M(-28.7%) |
| Dec 2004 | $13.09M(-7.8%) | $13.09M(-20.9%) |
| Sep 2004 | - | $16.55M(+19.6%) |
| Jun 2004 | - | $13.85M(-42.7%) |
| Mar 2004 | - | $24.18M(+70.3%) |
| Dec 2003 | $14.20M(-18.6%) | $14.20M(-11.8%) |
| Sep 2003 | - | $16.11M(+9.3%) |
| Jun 2003 | - | $14.74M(+25.1%) |
| Mar 2003 | - | $11.78M(-32.4%) |
| Dec 2002 | $17.44M(-69.3%) | $17.44M(-28.6%) |
| Sep 2002 | - | $24.42M(-57.9%) |
| Jun 2002 | - | $57.96M(+15.5%) |
| Mar 2002 | - | $50.20M(-11.7%) |
| Dec 2001 | $56.84M(+114.7%) | $56.84M(-9.2%) |
| Sep 2001 | - | $62.64M(-6.8%) |
| Jun 2001 | - | $67.23M(-6.5%) |
| Mar 2001 | - | $71.94M |
| Dec 2000 | $26.47M(+644.9%) | - |
| Dec 1999 | $3.55M(-59.7%) | - |
| Dec 1998 | $8.83M | - |
FAQ
- What is Exact Sciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Exact Sciences?
- What is Exact Sciences annual cash & cash equivalents year-on-year change?
- What is Exact Sciences quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Exact Sciences?
- What is Exact Sciences quarterly cash & cash equivalents year-on-year change?
What is Exact Sciences annual cash & cash equivalents?
The current annual cash & cash equivalents of EXAS is $600.89M
What is the all time high annual cash & cash equivalents for Exact Sciences?
Exact Sciences all-time high annual cash & cash equivalents is $1.49B
What is Exact Sciences annual cash & cash equivalents year-on-year change?
Over the past year, EXAS annual cash & cash equivalents has changed by -$4.49M (-0.74%)
What is Exact Sciences quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of EXAS is $347.13M
What is the all time high quarterly cash & cash equivalents for Exact Sciences?
Exact Sciences all-time high quarterly cash & cash equivalents is $1.49B
What is Exact Sciences quarterly cash & cash equivalents year-on-year change?
Over the past year, EXAS quarterly cash & cash equivalents has changed by -$360.00K (-0.10%)